NCT05052515View on ClinicalTrials.gov

The Effects of Dihydromiricetin on MASLD

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2024

Conditions
NAFLD
Interventions
DIETARY_SUPPLEMENT

Dihydromiricetin, Vitamin C, E and Choline

Patients with MASLD will be randomly allocated to receive capsules with Dihydromiricetin, Vitamin C, E and Choline

OTHER

Placebo

Patients with MASLD will be randomly allocated to receive placebo capsules

Trial Locations (1)

11527

"General Hospital of Athens Laiko", Athens

All Listed Sponsors
lead

University of Athens

OTHER

NCT05052515 - The Effects of Dihydromiricetin on MASLD | Biotech Hunter | Biotech Hunter